A recent study in the American Journal of Gastroenterology suggests the acid-reducing drug famotidine, better known as Pepcid, helps to improve clinical outcomes in coronavirus patients. When used on patients admitted to a Hartford hospital, researchers found famotidine was significantly associated with a reduction in death and intubation. Patients also had lower levels of blood markers for severe disease. While encouraging, more research is needed to truly know if the widely available drug improves outcomes for hospitalized COVID-19 patients.
That’s Gotta Hurt
The Injuries That Changed Sports Forever
Through the stories of a dozen athletes whose injuries and recovery advanced the field (including Joan Benoit, Michael Jordan, Brandi Chastain, and Tommy John), Dr. Geier explains how sports medicine makes sports safer for the pros, amateurs, student-athletes, and weekend warriors alike.Get the Book